Piacquad David 4
4 · Neumora Therapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Piacquad David
Director
Transactions
- Award
Common Stock
2024-06-13+20,100→ 20,100 total - Award
Stock Option (Right to Buy)
2024-06-13+28,571→ 28,571 totalExercise: $9.95Exp: 2034-06-12→ Common Stock (28,571 underlying)
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.
- [F2]100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.